GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Total Receivables

NKGen Biotech (NKGen Biotech) Total Receivables : $0.03 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech Total Receivables?

NKGen Biotech's Total Receivables for the quarter that ended in Mar. 2024 was $0.03 Mil.


NKGen Biotech Total Receivables Historical Data

The historical data trend for NKGen Biotech's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech Total Receivables Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
Total Receivables
0.07 0.10 0.03

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Total Receivables Get a 7-Day Free Trial 0.10 - 0.04 0.03 0.03

NKGen Biotech Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


NKGen Biotech Total Receivables Related Terms

Thank you for viewing the detailed overview of NKGen Biotech's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


NKGen Biotech (NKGen Biotech) Business Description

Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.